Tilray Overview
- Founded
-
2013

- Status
-
Public
- Employees
-
1,700

- Stock Symbol
-
TLRY

- Investments
-
14
- Share Price
-
$3.15
- (As of Friday Closing)
Tilray General Information
Description
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Contact Information
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Stock Exchange
NAS
Primary Office
- Post Office Box 20009
- 269 Erie Street South
- Leamington, Ontario N8H 3C4
- Canada
Tilray Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$3.15 | $3.12 | $3.02 - $17.91 | $1.51B | 481M | 26.7M | $0.18 |
Tilray Financials Summary
In Thousands, USD |
TTM 28-Feb-2022 | FY 2021 31-May-2021 | FY 2020 31-May-2020 | FY 2019 31-May-2019 |
---|---|---|---|---|
EV | 3,350,478 | 8,002,420 | 1,126,025 | 1,632,738 |
Revenue | 617,283 | 513,085 | 405,326 | 179,303 |
EBITDA | 229,538 | (249,177) | (54,145) | (26,187) |
Net Income | 41,681 | (367,421) | (102,540) | (25,037) |
Total Assets | 5,819,436 | 6,025,362 | 1,737,932 | 1,804,576 |
Total Debt | 732,871 | 938,659 | 302,144 | 361,118 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Tilray Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Tilray Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquir
Pharmaceuticals
Leamington, Canada
1,700
As of 2022
00000
0.000
0000-00-00
00000000
00000
Tilray Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cronos Group (Pharmaceuticals) | Corporation | Toronto, Canada | 000 | 00.000 | 000000000 | 00.000 |
00000000 | Formerly PE-Backed | Wakefield, MA | 0000 | 00000 | 000000000 | 00000 |
000000 000000 | Formerly Accelerator/Incubator backed | Smiths Falls, Canada | 0000 | 00000 | 000000000 | |
0000000000 0000000 | Corporation | Moncton, Canada | 000 | 00000 | 00000000 | |
0000 | Corporation | Kanata, Canada | 000 | 00000 | 000000000 | 00000 |
Tilray Executive Team (24)
Tilray Board Members (21)
Name | Representing | Role | Since |
---|---|---|---|
0000000 0000000 | Self | Board Member & Founder | 000 0000 |
000000000 00.00000 | Tilray | Board Member | 000 0000 |
00000 000000000 | Self | Board Member | 000 0000 |
00000 00000 | Self | Chief Executive Officer & Chairman | 000 0000 |
0000 00000 | Self | Board Member | 000 0000 |
Tilray Signals
Tilray Investments & Acquisitions (14)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000 | 30-May-2022 | 0000 | 00000 | Distributors/Wholesale | |
000000000000 | 07-Dec-2021 | 0000000000 | 00000 | Beverages | 00000 000 |
000000 000000 | 17-Aug-2021 | 0000 | 00000 | Specialty Retail | 00000 000 |
000000 | 30-Apr-2021 | 0000000000 | 00.000 | Pharmaceuticals | 0000000 0 |
Privateer Holdings | 12-Dec-2019 | Merger/Acquisition | 00.000 | Private Equity | 0000 0000 |
Tilray Subsidiaries (5)
Company Name | Industry | Location | Founded |
---|---|---|---|
Smith & Sinclair | Food Products | London, United Kingdom | 2014 |
000000000 00000000 | PE/Buyout | Seattle, WA | 0000 |
000000000000 00000 | Beverages | Breckenridge, CO | 0000 |
00000000 0000000 0 | Food Products | Winnipeg, Canada | 0000 |
000000 00000000 00 | Cultivation | Leamington, Canada | 0000 |